7. Cooperative Ua Lsp - 17 Feb 2026 Form 4 Insider Report for Evommune, Inc. (EVMN)

Signature
LSP 7 Cooperatief UA, By: LSP 7 Management B.V., its sole director, /s/ Martijn Kleijwegt, Managing Director and /s/ Rene Kuijten, Managing Director
Issuer symbol
EVMN
Transactions as of
17 Feb 2026
Net transactions value
+$9,999,998
Form type
4
Filing time
19 Feb 2026, 16:30:02 UTC
Previous filing
12 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LSP 7 Cooperative UA Director, 10%+ Owner C/O EQT LIFE SCIENCES,, JOHANNES VERMEERPLEIN 9, AMSTERDAM, NETHERLANDS LSP 7 Cooperatief UA, By: LSP 7 Management B.V., its sole director, /s/ Martijn Kleijwegt, Managing Director and /s/ Rene Kuijten, Managing Director 19 Feb 2026 0001876264

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVMN Common Stock Award $9,999,998 +358,680 +7.3% $27.88 5,288,313 17 Feb 2026 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held of record by LSP 7 Cooperatief UA ("LSP 7"). LSP 7 Management B.V. is the sole director of LSP 7. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe. As such, LSP 7 Management B.V., Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may be deemed to share beneficial ownership of the shares of Common Stock held by LSP 7. Each of Mr. Kleijwegt, Mr. Kuijten and Mr. Rothe disclaims beneficial ownership of such shares.